Matches in SemOpenAlex for { <https://semopenalex.org/work/W4308596291> ?p ?o ?g. }
Showing items 1 to 89 of
89
with 100 items per page.
- W4308596291 endingPage "37" @default.
- W4308596291 startingPage "27" @default.
- W4308596291 abstract "Introduction: Carbapenems are found in high concentrations in urine and are mainly eliminated by the kidney. Hence, they are the preferred treatment for pyelonephritis and complicated urinary tract infections (cUTIs) caused by extended-spectrum β-lactamase (ESBL) producing bacteria. The recent emergence of bacterial resistance to carbapenems has resulted in the need to search for alternative treatments for complicated UTIs. This review aims to evaluate the efficacy of Carbapenems versus Piperacillin/tacobactam (or the best available antibiotic therapy) in the management of pyelonephritis in patients with upper UTIs.
 Methods: A systematic review was carried out to compile all relevant studies on the use of Carbapenems versus Piperacillin/tacobactam in the treatment of upper urinary tract infections, namely pyelonephritis. A meta-analysis was carried out of the selected studies, including clinical trials composed of adult patients aged between 18 and 80 years old diagnosed with pyelonephritis. Primary screening of eligible studies was followed by the removal of duplicates and exclusion of non-eligible and unavailable full-text trials.
 Results: This review included four studies on the treatment of complicated pyelonephritis. The number of patients included per study varied and ranged from 62 to 421 cases. Different types and regimes of carbapenems were used, including intravenous Meropenem-Vaborbactam, Meropenem, Biapenem, Doripenem, or Ertapenem. The included studies compared carbapenems to Piperacillin/tazobactam or other best available therapies, such as third-generation cephalosporin. For microbial failure, the overall risk ratio was 0.95 with a confidence interval range between 0.62 and 1.45, and for clinical failure, the overall risk ratio was 0.86 with a confidence interval range between 0.51 and 1.45.
 Conclusions: According to the meta-analysis, the included studies showed that Carbapenems are not inferior to the comparators for the management of complicated urinary tract infections." @default.
- W4308596291 created "2022-11-12" @default.
- W4308596291 creator A5002242466 @default.
- W4308596291 creator A5038612361 @default.
- W4308596291 creator A5052390325 @default.
- W4308596291 creator A5060643196 @default.
- W4308596291 creator A5065767227 @default.
- W4308596291 creator A5068834704 @default.
- W4308596291 creator A5080990452 @default.
- W4308596291 creator A5081662341 @default.
- W4308596291 creator A5090919453 @default.
- W4308596291 date "2022-11-08" @default.
- W4308596291 modified "2023-10-01" @default.
- W4308596291 title "A Systematic Review and Meta-analysis of Efficacy of Carbapenems versus Other Best Available Antibiotics in the Management of Patients with Urinary Tract Infections" @default.
- W4308596291 doi "https://doi.org/10.9734/jpri/2022/v34i52b7219" @default.
- W4308596291 hasPublicationYear "2022" @default.
- W4308596291 type Work @default.
- W4308596291 citedByCount "0" @default.
- W4308596291 crossrefType "journal-article" @default.
- W4308596291 hasAuthorship W4308596291A5002242466 @default.
- W4308596291 hasAuthorship W4308596291A5038612361 @default.
- W4308596291 hasAuthorship W4308596291A5052390325 @default.
- W4308596291 hasAuthorship W4308596291A5060643196 @default.
- W4308596291 hasAuthorship W4308596291A5065767227 @default.
- W4308596291 hasAuthorship W4308596291A5068834704 @default.
- W4308596291 hasAuthorship W4308596291A5080990452 @default.
- W4308596291 hasAuthorship W4308596291A5081662341 @default.
- W4308596291 hasAuthorship W4308596291A5090919453 @default.
- W4308596291 hasBestOaLocation W43085962911 @default.
- W4308596291 hasConcept C126322002 @default.
- W4308596291 hasConcept C177713679 @default.
- W4308596291 hasConcept C2776685102 @default.
- W4308596291 hasConcept C2777637488 @default.
- W4308596291 hasConcept C2777821550 @default.
- W4308596291 hasConcept C2777858937 @default.
- W4308596291 hasConcept C2778193466 @default.
- W4308596291 hasConcept C2778266534 @default.
- W4308596291 hasConcept C2778368673 @default.
- W4308596291 hasConcept C2779375183 @default.
- W4308596291 hasConcept C2779631663 @default.
- W4308596291 hasConcept C501593827 @default.
- W4308596291 hasConcept C523546767 @default.
- W4308596291 hasConcept C54355233 @default.
- W4308596291 hasConcept C64778159 @default.
- W4308596291 hasConcept C71924100 @default.
- W4308596291 hasConcept C77411442 @default.
- W4308596291 hasConcept C86803240 @default.
- W4308596291 hasConcept C89423630 @default.
- W4308596291 hasConcept C94665300 @default.
- W4308596291 hasConcept C95190672 @default.
- W4308596291 hasConceptScore W4308596291C126322002 @default.
- W4308596291 hasConceptScore W4308596291C177713679 @default.
- W4308596291 hasConceptScore W4308596291C2776685102 @default.
- W4308596291 hasConceptScore W4308596291C2777637488 @default.
- W4308596291 hasConceptScore W4308596291C2777821550 @default.
- W4308596291 hasConceptScore W4308596291C2777858937 @default.
- W4308596291 hasConceptScore W4308596291C2778193466 @default.
- W4308596291 hasConceptScore W4308596291C2778266534 @default.
- W4308596291 hasConceptScore W4308596291C2778368673 @default.
- W4308596291 hasConceptScore W4308596291C2779375183 @default.
- W4308596291 hasConceptScore W4308596291C2779631663 @default.
- W4308596291 hasConceptScore W4308596291C501593827 @default.
- W4308596291 hasConceptScore W4308596291C523546767 @default.
- W4308596291 hasConceptScore W4308596291C54355233 @default.
- W4308596291 hasConceptScore W4308596291C64778159 @default.
- W4308596291 hasConceptScore W4308596291C71924100 @default.
- W4308596291 hasConceptScore W4308596291C77411442 @default.
- W4308596291 hasConceptScore W4308596291C86803240 @default.
- W4308596291 hasConceptScore W4308596291C89423630 @default.
- W4308596291 hasConceptScore W4308596291C94665300 @default.
- W4308596291 hasConceptScore W4308596291C95190672 @default.
- W4308596291 hasLocation W43085962911 @default.
- W4308596291 hasOpenAccess W4308596291 @default.
- W4308596291 hasPrimaryLocation W43085962911 @default.
- W4308596291 hasRelatedWork W1992925371 @default.
- W4308596291 hasRelatedWork W2024865137 @default.
- W4308596291 hasRelatedWork W2048376344 @default.
- W4308596291 hasRelatedWork W2116911994 @default.
- W4308596291 hasRelatedWork W2132068732 @default.
- W4308596291 hasRelatedWork W2149695402 @default.
- W4308596291 hasRelatedWork W2167973131 @default.
- W4308596291 hasRelatedWork W2318603684 @default.
- W4308596291 hasRelatedWork W2989326983 @default.
- W4308596291 hasRelatedWork W4308596291 @default.
- W4308596291 isParatext "false" @default.
- W4308596291 isRetracted "false" @default.
- W4308596291 workType "article" @default.